Literature DB >> 12201971

The risk of stroke following coronary revascularization -- a population-based long-term follow-up study.

Minna M Kaarisalo1, Pirjo Immonen-Räihä, Reijo J Marttila, Veikko Salomaa, Jorma Torppa, Jaakko Tuomilehto.   

Abstract

OBJECTIVE: To study the incidence and risk factors of stroke after coronary artery bypass grafting (CABG) or percutaneous transluminal coronary angioplasty (PTCA).
DESIGN: During 1983-1992, coronary revascularization procedures (n = 2160) were recorded in patients aged 35-64 years as part of the population-based FINMONICA Myocardial Infarction Register. The FINMONICA Stroke Register and National Hospital Discharge Register were used to ascertain subsequent stroke events in such patients.
RESULTS: During the average follow-up of 5.83 years, 155 patients (7.2%) had a stroke. The cumulative incidence of stroke was 1.55% in the first year after revascularization and varied between 0.8 and 1.4% during subsequent years. In Cox proportional hazard models the relative risk of stroke was 3.01 (p = 0.0007) for a previous stroke, 2.61 (p = 0.0001) for diabetes mellitus, 2.15 (p = 0.007) for low income (compared with high income), 2.06 (p = 0.03) for male sex, and 1.43 (p = 0.02) for a 10-year increment in age.
CONCLUSION: The incidence of stroke during the first year after revascularization was five times higher than among the age- and sex-matched general population. Patients with a previous stroke, diabetes mellitus, advanced age, male sex and low socioeconomic status need special attention because of increased risk of stroke after CABG or PTCA.

Entities:  

Mesh:

Year:  2002        PMID: 12201971     DOI: 10.1080/14017430260180391

Source DB:  PubMed          Journal:  Scand Cardiovasc J        ISSN: 1401-7431            Impact factor:   1.589


  1 in total

1.  Patient characteristics and comorbidities associated with cerebrovascular accident following acute myocardial infarction in the United States.

Authors:  Nassim Naderi; Hossein Masoomi; Tahseen Mozaffar; Shaista Malik
Journal:  Int J Cardiol       Date:  2014-05-16       Impact factor: 4.164

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.